Pharmaceutical Care Management
PCMA'S VISION AND MISSION ARE TO HELP PEOPLE OPTIMIZE PRESCRIPTION DRUG THERAPY TO LIVE HEALTHIER LIVES. WE STRIVE TO CREATE A FAVORABLE PUBLIC POLICY AND BUSINESS ENVIRONMENT FOR THE PHARMACEUTICAL CARE BENEFITS MANAGERS INDUSTRY (PBM) TO ACHIEVE POSITIVE HEALTHCARE OUTCOMES FOR PATIENTS BY MANAGING ACCESS TO APPROPRIATE, AFFORDABLE, AND SAFE PRESCRIPTION DRUGS.
Financial Overview
From 2024 IRS Form 990-PF · View filing
Total Assets
$26.6M
-1.4% YoY
Annual Giving
$1.2M
+366.0% YoY
Grant Count
15
+7.1% YoY
Avg Grant Size
$82K
+334.9% YoY
About Pharmaceutical Care Management
Based on IRS filings
Pharmaceutical Care Management is a nonprofit organization, based in WASHINGTON, DC. IRS filing data is available from 2020 through 2024. As of 2024, the organization holds $26.6M in total assets. In 2024, it awarded 15 grants totaling $1.2M. Net investment income was $1.1M.
Ready to take the next step with Pharmaceutical Care Management?
Geographic Focus
Where this funder awards grants
Grant Distribution by State
States
Cities
Financial History
Multi-year comparison from IRS filings
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Total Assets | $26,559,945 | $26,947,681 | $25,360,425 |
| Revenue | $54,188,107 | $61,687,774 | $47,371,719 |
| Expenses | $55,182,220 | $62,339,506 | $47,414,705 |
| Qualifying Distributions | — | — | — |
| Net Investment Income | $1,142,496 | $809,045 | $60,050 |
| Distributable Amount | — | — | — |
Giving Over Time
Total grant dollars and number of grants per year
Grant Insights
How this funder distributes its grants
Top Recipients
Top 10 recipients in 2024
Grant Size Distribution
56 grants across all recorded years
Giving History
Grant recipients and amounts by year
No grants recorded for .
Leadership & Key People
Officers and directors from IRS filings
Compensation Overview
From 2024 IRS filing
From 2024 filing
| Name | Title | Hours | Compensation |
|---|---|---|---|
| AMY MULDERRY | DIRECTOR AS OF 04/2024 | 1 | — |
| RAY MARSELLA | DIRECTOR | 1 | — |
| DAVID JOYNER | DIRECTOR | 1 | — |
| PATRICK CONWAY | DIRECTOR | 1 | — |
| ADAM KAUTZNER | DIRECTOR | 1 | — |
| JAMES GARTNER | DIRECTOR | 1 | — |
| MOSTAFA KAMAL | DIRECTOR | 1 | — |
| WILLIAM FLEMING | DIRECTOR UNTIL 06/2024 | 1 | — |
| PAUL MARCHETTI | DIRECTOR UNTIL 04/2024 | 1 | — |
| CHRIS DUPAUL | DIRECTOR UNTIL 12/2024 | 1 | — |
| JUAN CARLOS SCOTT | PRESIDENT & CEO | 40 | $1,858,753 |
| BRIAN MCCARTHY | CHIEF OPERATIONS OFFICER | 40 | $1,074,258 |
| KRISTIN BASS - CHIEF POLICY AND | EXTERNAL AFFAIRS OFF UNTIL 02/2024 | 40 | $153,464 |
| JOHN LINEHAN | GENERAL COUNSEL | 40 | $634,371 |
| AGNITA KOTE | CHIEF FINANCIAL OFFICER | 40 | $321,387 |
| LAUREN ROWLEY | SVP STATE AFFAIRS UNTIL 03/2024 | 40 | $462,384 |
| KATIE PAYNE | SVP PUBLIC AFFAIRS | 40 | $703,814 |
| TIM DUBE | SVP POLICY AND REGULATORY INSIGNTS | 40 | $538,944 |
| LUCIA LEBENS | SVP FEDERAL AFFAIRS | 40 | $660,069 |
| MELODIE SHRADER | SVP STATE AFFAIRS AS OF 04/24 | 40 | $321,388 |
| JONATHAN HEAFITZ | VP FEDERAL AFFAIRS | 40 | $586,611 |
| ANGELA BANKS | VP POLICY | 40 | $440,408 |
| AMANDA FROST | VP RESEARCH | 40 | $384,596 |
| WILLIAM HEAD | AVP STATE AFFAIRS | 40 | $338,507 |
| HEATHER CASCONE | AVP STATE AFFAIRS | 40 | $332,123 |
Related Funders
Similar funders by location and focus area
Demand Justice Initiative
WASHINGTON, DC
Assets
$7.6M
Grants
1
Total Given
$225K
American Academic Leadership Institute
WASHINGTON, DC
Assets
$3.6M
Grants
2
Total Given
$50K
Cnfa
WASHINGTON, DC
Assets
$18.3M
Grants
9
Total Given
$4.2M
Partnership for a Healthier America
WASHINGTON, DC
Assets
$10.8M
Grants
12
Total Given
$350K
Association of Schools of Allied Health
WASHINGTON, DC
Assets
$2.3M
Grants
2
Total Given
$60K
Fulcrum Foundation Inc
WASHINGTON, DC
Assets
$53K
Grants
10
Total Given
$13K
Data last updated April 2026. Sourced from IRS Form 990-PF filings.
What could you do with Pharmaceutical Care Management on Grantable?
- Assess strategic fit with your organization
- Draft a tailored letter of inquiry
- Find open RFPs from this funder
- Monitor for new funding opportunities